Understanding Alzheimer's Disease Risk with Advanced Molecular Tools
Multi-Omics Core
This core facility uses advanced molecular techniques to understand how a gene called APOE affects your risk for Alzheimer's disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Jacksonville NIH-funded |
| Lab location | 1 site (Jacksonville, United States) |
| Project ID | NIH-11105813 on NIH RePORTER |
What this research studies
We are using cutting-edge technologies to look closely at the proteins, fats, and other small molecules in human tissues and fluids, as well as in models of Alzheimer's disease. By studying these tiny building blocks, we hope to uncover the specific changes that happen in the body due to the APOE gene, which is known to influence Alzheimer's risk. This work helps us understand the complex ways Alzheimer's develops at a very detailed level. Our goal is to find new ways to predict, diagnose, treat, and even prevent this condition.
Who could benefit from this research
Good fit: This foundational research is for anyone interested in the underlying causes of Alzheimer's disease, especially those with an APOE genetic risk factor, as it uses human samples to advance understanding.
Not a fit: Patients not affected by Alzheimer's disease or its risk factors, or those not participating in related studies that utilize this core's services, may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to predict, diagnose, treat, and prevent Alzheimer's disease by identifying key molecular changes.
How similar studies have performed: While this core focuses on advancing and applying technologies, similar 'omics' approaches have shown success in identifying molecular markers in various diseases, suggesting a strong foundation for this work.
Where this research is happening
Jacksonville, United States
- Mayo Clinic Jacksonville — Jacksonville, United States (Active)
Researchers
- Principal investigator: Peng, Junmin — Mayo Clinic Jacksonville
- Study coordinator: Peng, Junmin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.